Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

46.19
Delayed Data
As of May 27
 +0.36 / +0.79%
Today’s Change
31.25
Today|||52-Week Range
58.46
-18.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash63.8M44.8M31.0M74.2M
 
 
 
 
 
Short Term Investment Cash13.6M-19.0M-13.8M43.2M
 
 
 
 
 
Cash & Short Term Investments173.0M145.7M193.8M379.2M
 
 
 
 
 
 
ReceivablesReceivables14.1M23.0K--0.00
 
 
 
 
InventoriesInventories0.00----0.00--
 
Current AssetsOther Current Assets2.2M2.7M4.4M4.9M
 
 
 
 
 
Current Assets189.3M148.5M198.2M384.1M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross36.2M30.1M31.3M30.3M
 
 
 
 
 
Depreciation-34.3M-28.3M-28.7M-26.9M
 
 
 
 
 
Other Assets0.000.000.000.00--
Total Assets196.0M154.7M243.0M474.8M
 
 
 
 
 
 
LiabilitiesAccounts Payable911.0K101.0K246.0K2.6M
 
 
 
 
 
Accrued Expenses4.3M4.6M5.0M12.1M
 
 
 
 
 
Other Current Liabilities10.9M8.2M8.9M15.8M
 
 
 
 
 
Other Liabilities15.6M11.7M15.7M25.7M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities3.2M2.9M2.5M1.8M
 
 
 
 
 
Total Liabilities41.6M34.3M34.3M50.3M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity154.4M120.4M208.7M424.5M
 
 
 
 
 
Total Shareholder Equity154.4M120.4M208.7M424.5M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding66.4M67.4M76.5M86.3M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.